ArticleBMC infectious diseases2025

Efficacy and safety of PEG-IFN α-2b and tenofovir amibufenamide in combination therapy for chronic hepatitis B.

Wen Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.